Sasamoto Children's Clinic

Setagaya-ku, Tokyo 157-0066

2 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema

Studies at this site

• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema — Recruiting now
• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema — Recruiting now